About Rivastigmine
            
            Class: | Cholinesterase inhibitor  
Use: | Treatment of mild to moderate dementia associated with Alzheimer's disease and Parkinson's disease  
Adult dose: | 9.5 mg/24 hours transdermal patch applied once daily; may be increased to 13.3 mg/24 hours after a minimum of 4 weeks if tolerated  
Pediatric dose: | Safety and efficacy not established in pediatric populations  
Side effects: | Nausea, vomiting, diarrhea, anorexia, weight loss, insomnia, dizziness, fatigue, and skin reactions at the appli
         
        
            
                
                
                    
                        Drug Class
                    
                    Cholinesterase inhibitor
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of mild to moderate dementia associated with Alzheimer's disease and Parkinson's disease
                 
                
                
                    
                        Storage Requirements
                    
                    Store at room temperature (20°C to 25°C or 68°F to 77°F); protect from moisture; do not store in the refrigerator or freezer
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: ACINO AG  , Germany
                    
                    
                    Package Size
                    Sachet x 30
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 356.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        9.5 mg/24 hours transdermal patch applied once daily; may be increased to 13.3 mg/24 hours after a minimum of 4 weeks if tolerated
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric populations
                    
                 
                
                
                    
                        Side Effects
                    
                    Nausea, vomiting, diarrhea, anorexia, weight loss, insomnia, dizziness, fatigue, and skin reactions at the application site
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Known hypersensitivity to rivastigmine or any component of the patch; history of severe skin reactions to rivastigmine; use with caution in patients with a history of asthma or obstructive pulmonary disease
         
        
        
            
                Important Warnings
            
            May cause bradycardia; monitor heart rate; use caution in patients with a history of seizures; may exacerbate conditions with increased cholinergic activity; not recommended for use in patients with severe hepatic impairment
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.